Owkin Unveils AI-Driven Oncology And Immunology Pipeline
orsonamiri
  • Reads 4
  • Votes 0
  • Parts 1
  • Time <5 mins
  • Reads 4
  • Votes 0
  • Parts 1
  • Time <5 mins
orsonamiri
Ongoing, First published May 24, 2024
biotechnology
Owkin a TechBio unicorn, unveils a new drug pipeline in oncology & immunology. Partnering with Idorsia, Owkin will develop & commercialize OKN4395, a cutting-edge dual inhibitor of prostanoid receptors EP2 and EP4, using advanced causal AI for precision medicine.
All Rights Reserved
biotechnology
Table of contents

1 part

Sign up to add Owkin Unveils AI-Driven Oncology And Immunology Pipeline to your library and receive updates
or
#264biotechnology
Content Guidelines
You may also like
Brittanie's Writer Room by BrittanieCharmintine
15 parts Ongoing
A place for all things Brittanie!
You may also like
Slide 1 of 1
Brittanie's Writer Room cover

Brittanie's Writer Room

15 parts Ongoing

A place for all things Brittanie!

More details